SS
RPRX icon

Sunbelt Securities’s Royalty Pharma RPRX Stock Holding History

Sunbelt Securities’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.4K Hold
280
– – ﹤0.01% 1419
2025
Q4 		$10.8K Hold
280
– – ﹤0.01% 1418
2025
Q3 		$9.88K Buy
+280
New +$10.1K ﹤0.01% 1450
2025
Q2 		– Sell
-25
Closed -$784 – 1877
2025
Q1 		$784 Buy
+25
New +$792 ﹤0.01% 1670

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Sunbelt Securities's RPRX Position: Q1 2026 in Review

Sunbelt Securities held its Royalty Pharma (RPRX) position steady in Q1 2026 at 280 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1419.

Sunbelt Securities first reported a position in RPRX in Q1 2025 and has held it in 4 quarters since. 590 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Sunbelt Securities held 280 shares of Royalty Pharma worth $13.4K as of Q1 2026.
  • Sunbelt Securities left its Royalty Pharma share count unchanged in Q1 2026.
  • Royalty Pharma made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1419 holding.
  • Sunbelt Securities first reported a position in Royalty Pharma in Q1 2025 and has held it in 4 quarters since.
  • 590 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.